• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的免疫生物学与纳米治疗:最新进展

Immunobiology and nanotherapeutics of severe acute respiratory syndrome 2 (SARS-CoV-2): a current update.

作者信息

Mba Ifeanyi Elibe, Sharndama Hyelnaya Cletus, Osondu-Chuka Goodness Ogechi, Okeke Onyekachi Philomena

机构信息

Department of Microbiology, University of Nigeria, Nsukka, Nigeria.

出版信息

Infect Dis (Lond). 2021 Aug;53(8):559-580. doi: 10.1080/23744235.2021.1916071. Epub 2021 Apr 27.

DOI:10.1080/23744235.2021.1916071
PMID:33905282
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8095391/
Abstract

The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) constitutes the most significant global public health challenge in a century. It has reignited research interest in coronavirus. While little information is available, research is currently in progress to comprehensively understand the general biology and immune response mechanism against SARS-CoV-2. The spike proteins (S protein) of SARS-CoV-2 perform a crucial function in viral infection establishment. ACE2 and TMPRSS2 play a pivotal role in viral entry. Upon viral entry, the released pro-inflammatory proteins (cytokines and chemokines) cause the migration of the T cells, monocytes, and macrophages to the infection site. IFNϒ released by T cells initiates a loop of pro-inflammatory feedback. The inflammatory state may further enhance with an increase in immune dysfunction responsible for the infection's progression. A treatment approach that prevents ACE2-mediated viral entry and reduces inflammatory response is a crucial therapeutic intervention strategy, and nanomaterials and their conjugates are promising candidates. Nanoparticles can inhibit viral entry and replication. Nanomaterials have also found application in targeted drug delivery and also in developing a vaccine against SARS-CoV-2. Here, we briefly summarize the origin, transmission, and clinical features of SARS-CoV-2. We then discussed the immune response mechanisms of SARS-CoV-2. Finally, we further discussed nanotechnology's potentials as an intervention strategy against SARS-CoV-2 infection. All these understandings will be crucial in developing therapeutic strategies against SARS-CoV-2.

摘要

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的出现是一个世纪以来最重大的全球公共卫生挑战。它重新点燃了人们对冠状病毒的研究兴趣。尽管可用信息很少,但目前正在进行研究以全面了解针对SARS-CoV-2的一般生物学和免疫反应机制。SARS-CoV-2的刺突蛋白(S蛋白)在病毒感染的建立过程中发挥着关键作用。血管紧张素转换酶2(ACE2)和跨膜丝氨酸蛋白酶2(TMPRSS2)在病毒进入过程中起关键作用。病毒进入后,释放的促炎蛋白(细胞因子和趋化因子)会导致T细胞、单核细胞和巨噬细胞迁移到感染部位。T细胞释放的干扰素γ启动了促炎反馈循环。随着负责感染进展的免疫功能障碍增加,炎症状态可能会进一步增强。一种防止ACE2介导的病毒进入并减少炎症反应的治疗方法是一种关键的治疗干预策略,纳米材料及其缀合物是很有前景的候选者。纳米颗粒可以抑制病毒进入和复制。纳米材料还在靶向药物递送以及开发针对SARS-CoV-2的疫苗方面得到了应用。在此,我们简要总结了SARS-CoV-2的起源、传播和临床特征。然后我们讨论了SARS-CoV-2的免疫反应机制。最后,我们进一步讨论了纳米技术作为对抗SARS-CoV-2感染的干预策略的潜力。所有这些认识对于制定针对SARS-CoV-2的治疗策略至关重要。

相似文献

1
Immunobiology and nanotherapeutics of severe acute respiratory syndrome 2 (SARS-CoV-2): a current update.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的免疫生物学与纳米治疗:最新进展
Infect Dis (Lond). 2021 Aug;53(8):559-580. doi: 10.1080/23744235.2021.1916071. Epub 2021 Apr 27.
2
Targeting the viral-entry facilitators of SARS-CoV-2 as a therapeutic strategy in COVID-19.针对 SARS-CoV-2 的病毒进入促进剂作为 COVID-19 的治疗策略。
J Med Virol. 2021 Sep;93(9):5260-5276. doi: 10.1002/jmv.27019. Epub 2021 May 3.
3
The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19.TMPRSS2 抑制剂那法莫司他可降低 COVID-19 小鼠模型中的 SARS-CoV-2 肺部感染。
mBio. 2021 Aug 31;12(4):e0097021. doi: 10.1128/mBio.00970-21. Epub 2021 Aug 3.
4
SARS-CoV-2 and SARS-CoV Spike-Mediated Cell-Cell Fusion Differ in Their Requirements for Receptor Expression and Proteolytic Activation.SARS-CoV-2 和 SARS-CoV 的刺突介导的细胞融合在受体表达和蛋白水解激活的要求上存在差异。
J Virol. 2021 Apr 12;95(9). doi: 10.1128/JVI.00002-21.
5
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)进入细胞依赖于 ACE2 和 TMPRSS2,可被一种临床验证的蛋白酶抑制剂所阻断。
Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5.
6
Contributions of human ACE2 and TMPRSS2 in determining host-pathogen interaction of COVID-19.人类血管紧张素转换酶2(ACE2)和跨膜丝氨酸蛋白酶2(TMPRSS2)在决定新型冠状病毒肺炎(COVID-19)宿主-病原体相互作用中的作用。
J Genet. 2021;100(1). doi: 10.1007/s12041-021-01262-w.
7
The expression of hACE2 receptor protein and its involvement in SARS-CoV-2 entry, pathogenesis, and its application as potential therapeutic target.hACE2 受体蛋白的表达及其在 SARS-CoV-2 进入、发病机制中的作用及其作为潜在治疗靶点的应用。
Tumour Biol. 2021;43(1):177-196. doi: 10.3233/TUB-200084.
8
Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.弗林蛋白酶和 TMPRSS2 在 SARS-CoV-2 感染中的独特作用。
J Virol. 2022 Apr 27;96(8):e0012822. doi: 10.1128/jvi.00128-22. Epub 2022 Mar 28.
9
, and Models for Monitoring SARS-CoV-2 Spike/Human ACE2 Complex, Viral Entry and Cell Fusion.用于监测 SARS-CoV-2 刺突/人 ACE2 复合物、病毒进入和细胞融合的模型。
Viruses. 2021 Feb 25;13(3):365. doi: 10.3390/v13030365.
10
Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Based Novel Epitopes Induce Potent Immune Responses and Inhibit Viral Replication .严重急性呼吸综合征冠状病毒 2 刺突蛋白新型表位诱导强烈的免疫反应并抑制病毒复制。
Front Immunol. 2021 Mar 26;12:613045. doi: 10.3389/fimmu.2021.613045. eCollection 2021.

引用本文的文献

1
Nanomaterials for the Treatment of Contamination by Nosocomial Pathogens in Intensive Care Units.用于治疗重症监护病房医院病原体污染的纳米材料
Int J Nanomedicine. 2025 Aug 22;20:10213-10231. doi: 10.2147/IJN.S539190. eCollection 2025.
2
Recent and advanced nano-technological strategies for COVID-19 vaccine development.用于新冠疫苗研发的最新及先进纳米技术策略
Methods Microbiol. 2022;50:151-188. doi: 10.1016/bs.mim.2022.03.001. Epub 2022 Apr 18.
3
Nanotechnology as a Promising Approach to Combat Multidrug Resistant Bacteria: A Comprehensive Review and Future Perspectives.纳米技术作为对抗多重耐药细菌的一种有前景的方法:综述与未来展望
Biomedicines. 2023 Jan 31;11(2):413. doi: 10.3390/biomedicines11020413.
4
A Detailed Overview of Immune Escape, Antibody Escape, Partial Vaccine Escape of SARS-CoV-2 and Their Emerging Variants With Escape Mutations.SARS-CoV-2 及其具有逃逸突变的新兴变异株的免疫逃逸、抗体逃逸、部分疫苗逃逸的详细概述。
Front Immunol. 2022 Feb 9;13:801522. doi: 10.3389/fimmu.2022.801522. eCollection 2022.
5
Opportunities for Nanomedicine in Infection.纳米医学在感染领域的机遇
Antibiotics (Basel). 2021 Aug 5;10(8):948. doi: 10.3390/antibiotics10080948.
6
Nanoparticles as therapeutic options for treating multidrug-resistant bacteria: research progress, challenges, and prospects.纳米颗粒作为治疗多重耐药菌的治疗选择:研究进展、挑战和前景。
World J Microbiol Biotechnol. 2021 May 28;37(6):108. doi: 10.1007/s11274-021-03070-x.

本文引用的文献

1
Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients.致病性T细胞和炎性单核细胞在重症COVID-19患者中引发炎症风暴。
Natl Sci Rev. 2020 Jun;7(6):998-1002. doi: 10.1093/nsr/nwaa041. Epub 2020 Mar 13.
2
Isolation of 2019-nCoV from a Stool Specimen of a Laboratory-Confirmed Case of the Coronavirus Disease 2019 (COVID-19).从一名实验室确诊的2019冠状病毒病(COVID-19)病例的粪便样本中分离出2019新型冠状病毒。
China CDC Wkly. 2020 Feb 21;2(8):123-124.
3
Early combination treatment with existing HIV antivirals: an effective treatment for COVID-19?早期联合使用现有 HIV 抗病毒药物:治疗 COVID-19 的有效方法?
Eur Rev Med Pharmacol Sci. 2021 Mar;25(5):2435-2448. doi: 10.26355/eurrev_202103_25285.
4
Notes from the Field: SARS-CoV-2 Transmission Associated with High School Football Team Members - Florida, September-October 2020.实地记录:2020年9月至10月,佛罗里达州与高中橄榄球队队员相关的新冠病毒传播情况
MMWR Morb Mortal Wkly Rep. 2021 Mar 19;70(11):402-404. doi: 10.15585/mmwr.mm7011a3.
5
Predictors of infection, symptoms development, and mortality in people with SARS-CoV-2 living in retirement nursing homes.居住在养老院中的 SARS-CoV-2 感染者的感染、症状发展和死亡率的预测因素。
PLoS One. 2021 Mar 16;16(3):e0248009. doi: 10.1371/journal.pone.0248009. eCollection 2021.
6
SARS-CoV-2 Transmission From People Without COVID-19 Symptoms.SARS-CoV-2 从无 COVID-19 症状者传播。
JAMA Netw Open. 2021 Jan 4;4(1):e2035057. doi: 10.1001/jamanetworkopen.2020.35057.
7
Genomic Evidence of In-Flight Transmission of SARS-CoV-2 Despite Predeparture Testing.基因组证据表明,尽管在出发前进行了检测,但仍有 SARS-CoV-2 在飞行途中传播。
Emerg Infect Dis. 2021 Mar;27(3):687-693. doi: 10.3201/eid2703.204714. Epub 2021 Jan 5.
8
Rapid Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 in Detention Facility, Louisiana, USA, May-June, 2020.2020 年 5 月至 6 月,美国路易斯安那州拘留设施中严重急性呼吸综合征冠状病毒 2 的快速传播。
Emerg Infect Dis. 2021 Feb;27(2):421-429. doi: 10.3201/eid2702.204158. Epub 2021 Jan 4.
9
CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells.CD147-刺突蛋白是 SARS-CoV-2 感染宿主细胞的新途径。
Signal Transduct Target Ther. 2020 Dec 4;5(1):283. doi: 10.1038/s41392-020-00426-x.
10
Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19: A Randomized Clinical Trial.羟氯喹对 COVID-19 住院患者 14 天临床状态的影响:一项随机临床试验。
JAMA. 2020 Dec 1;324(21):2165-2176. doi: 10.1001/jama.2020.22240.